标题 |
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
特瑞普利单抗联合贝伐珠单抗与索拉非尼一线治疗晚期肝细胞癌(HEPATORCH)的比较:一项随机、开放标签、3期试验
|
网址 |
求助人暂未提供
|
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
其它 |
作者:Prof Yinghong Shi, MDa,† ∙ Prof Guohong Han, MDb,† ∙ Prof Jian Zhou, MDa,† ∙ Prof Xuetao Shi, MDc ∙ Prof Weidong Jia, MDd ∙ Prof Ying Cheng, MDe ∙ Prof Yongdong Jin, MDf ∙ Xiangdong Hua, MMedg ∙ Prof Tianfu Wen, MDh ∙ Prof Jianbing Wu, 链接:https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00059-7/abstract |
求助人 | |
下载 | 暂无链接,等待应助者上传 |